Collected about 2.7k dividend for this month. It’s about 40% higher than projected due to the early distribution from AReit and CRCT before their preferential offerings (PO). Which also means there will slightly less dividend next year.
With DBS up by more than 20% in November, I sold 1/3 of my holdings in late last month at $25.34 and booked an 18% return. Part of the proceed is used to apply for AReit and CRCT POs and part of it to add more Plife, UMS and Venture.
| Counter | Purchased Price | Average Price (2020 New Portfolio) |
| Ascendas Reit | $2.96 (PO) | $2.96 |
| CapitaRetail China Trust | $1.17 (PO) | $1.38 |
| Parkwaylife Reit | $3.85 | $3.25 |
| UMS | $1.02 | $1.01 |
| Venture | $18.85 | $16.43 |
I also returned some to cash account such that I have zero net cash injection to portfolio for the year. If CPF is included, about 21k is withdrawn from the portfolio this year.
On the US side, I have injected slightly more cash to both my SaaS mini-fund and MFRS micro-caps fund since the last update. For SaaS, I added more TEAM, DOCU, CRM, NOW, TDOC, and VEEV. I decided to weigh my allocation based on my conviction of the counters using the following guide.
- Star – beyond 10%
- Tier 1 – 7.5% to 10%
- Tier 2 – 5.0% to 7.5%
- Tier 3 – 2.5% to 5.0%
After the purchase, this is how they stand in this portfolio. As I am still comfortable with theTradeDesk’s current position in this portfolio, I decided not to adjust it even though it’s not in the Star Tier yet.
Yup, that’s it for this month. As mentioned in my review, I have probably fine-tuned my portfolio too much this year. Hopefully, I can at least half the amount of actions next year.
Towards Financial Independence 